Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6

Acquisition of resistance to cisplatin is a major impediment to the success of cisplatin-based combination therapies for cancer. Recent studies indicate that exosomal miRNAs derived from drug-resistant tumour cells can confer resistance properties to recipient cells by a horizontal transfer mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Raji, Grace R., Poyyakkara, Aswini, Krishnan, Anjali Kunhi, Maurya, Ashutosh Kumar, Changmai, Udeshna, Shankar, Sharath S., Kumar, V. B. Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229894/
https://www.ncbi.nlm.nih.gov/pubmed/34071504
http://dx.doi.org/10.3390/cells10061341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229894/
https://www.ncbi.nlm.nih.gov/pubmed/34071504
http://dx.doi.org/10.3390/cells10061341

Ejemplares similares